×
ADVERTISEMENT

synovial sarcoma

FDA Grants Accelerated Approval to Tecelra for Unresectable or Metastatic Synovial Sarcoma

The FDA has granted accelerated approval to afamitresgene autoleucel (Tecelra, Adaptimmune LLC), a ...

AUGUST 2, 2024

New Analysis Sheds Light on Recurrent Synovial Sarcoma in Younger Patients

A new analysis reported that roughly one-fourth of young patients with synovial sarcoma experience a recurrence, ...

SEPTEMBER 27, 2016

Load more